Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL Study
2010-022413-26Phase 4Terminated
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Clinical progression within 24 weeks. Started Apr 2011; status: terminated.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on 2010-022413-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022413-26.